pharma whats-next-drug-pricing-2023 
pharmaphorum
DECEMBER 15, 2022
A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. of total sales – under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) introduced in 2019. VPAS tax on top. .
Pharmaceutical Technology
OCTOBER 5, 2022
Technology is advancing the possibilities of healthcare treatments, from the development of innovative new drugs to freeing up time for doctors thanks to monitoring devices for patients with conditions such as diabetes and high blood pressure. However, this is not typically the case in the UK health and pharma segments.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
AUGUST 22, 2023
Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. What are complex generics? Opportunities Originator pharma companies are developing more and more complex products these days.
The Pharma Data
NOVEMBER 5, 2020
By a separate press release, the Company has today announced its intention to distribute the BUPI project to the shareholders of Moberg Pharma through a Lex Asea distribution with a subsequent listing on Nasdaq First North Growth Market during the Q1 of 2021. STOCKHOLM , Nov. Summary.
Drug Discovery World
JANUARY 26, 2023
DDW Editor Reece Armstrong takes a look at the pharmaceutical research and development market in 2023 and asks key opinion leaders what challenges and trends will emerge throughout the year. billion showed the pharma giant taking further steps into the oncology market and developing its speciality medicines vaccines portfolio.
pharmaphorum
JANUARY 9, 2023
What’s often forgotten is the backwards-facing, reflective mode: when we predicted unprecedented challenge in the past, did it really happen? This Nine for 2023 three-part series will argue that, this year, the future-facing Janus prediction of unprecedented and transformative change is true. Things fall apart: deglobalisation.
Drug Discovery World
FEBRUARY 22, 2023
Advances in new manufacturing technology accelerate Back in 2019 I wrote a paper about transforming the drug life cycle, which included what I felt were the opportunities and the challenges that were going to affect the pharmaceutical sector over the next few years.
Expert insights. Personalized for you.
72 
Let's personalize your content